Carina Biotech
Adelaide, AU · Founded 2016 · 16 employees on LinkedIn · 1 known investors
Find your way into Carina Biotech
Sign up to see every warm intro you have to Carina Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carina Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
Founders & leadership
DD

Dr Deborah RathjenChief Executive Officer & Managing Director
PS
Professor Shaun McCollChief Scientific Officer
Board
CB
Claudine BonderHead, Vascular Biology and Cell Trafficking Laboratory
Investors · 1
Tenmilelisted by Tenmile
How we know: labiotech.eu · Not right? Tell us
Frequently asked questions
- What does Carina Biotech do?
- Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
- Who are Carina Biotech's investors?
- Carina Biotech's investors include Tenmile.
- Where is Carina Biotech headquartered?
- Carina Biotech is headquartered in Adelaide, AU.


